1-1 of 1
James A. Borowiec, PhD
Close
Sort by
Journal Articles

Cell Line-Dependent Synergy Between the PARP Inhibitor Veliparib and the Proteasome Inhibitor Bortezomib in the Killing of Myeloma Cells

Alex Xu, B.A., Amitabha Mazumder, MD, James A. Borowiec, PhD
Journal: Blood
Blood (2015) 126 (23): 5556.
https://doi.org/10.1182/blood.V126.23.5556.5556
Published: 2015